A. Yagciolglu Et Al. , "Double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety," 24th CINP Congress , vol.7, Paris, France, 2004
Yagciolglu, A. Et Al. 2004. Double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety. 24th CINP Congress , (Paris, France).
Yagciolglu, A., Akdede, B., Turgut, T., Tumuklu, M., Yazici, M., ALPTEKİN, K., ... Ertugrul, A.(2004). Double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety . 24th CINP Congress, Paris, France
Yagciolglu, AEA Et Al. "Double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety," 24th CINP Congress, Paris, France, 2004
Yagciolglu, AEA Et Al. "Double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety." 24th CINP Congress , Paris, France, 2004
Yagciolglu, A. Et Al. (2004) . "Double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety." 24th CINP Congress , Paris, France.
@conferencepaper{conferencepaper, author={AEA Yagciolglu Et Al. }, title={Double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety}, congress name={24th CINP Congress}, city={Paris}, country={France}, year={2004}}